When do biologic drug patents expire and when will biosimilars launch?

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Patent Expiration
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	2004-05-05	⤷ Subscribe	⤷ Subscribe
Amphastar Pharmaceuticals, Inc.	AMPHADASE	hyaluronidase	Injection	021665	2004-10-26	⤷ Subscribe	⤷ Subscribe
Halozyme Therapeutics, Inc.	HYLENEX RECOMBINANT	hyaluronidase human	Injection	021859	2005-12-02	⤷ Subscribe	⤷ Subscribe
Halozyme Therapeutics, Inc.	HYLENEX RECOMBINANT	hyaluronidase human	Injection	021859	2005-12-02	⤷ Subscribe	⤷ Subscribe
Halozyme Therapeutics, Inc.	HYLENEX RECOMBINANT	hyaluronidase human	Injection	021859	2005-12-02	⤷ Subscribe	⤷ Subscribe
Halozyme Therapeutics, Inc.	HYLENEX RECOMBINANT	hyaluronidase human	Injection	021859	2005-12-02	⤷ Subscribe	⤷ Subscribe
Halozyme Therapeutics, Inc.	HYLENEX RECOMBINANT	hyaluronidase human	Injection	021859	2005-12-02	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Patent Expiration